The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins

Journal of Virology

Volumn 77, Issue 8, 2003, Pages 4539-4545

  Odeberg, Jenny ^a   Browne, Helena ^b   Metkar, Sunil ^c   Froelich, Christopher J ^c   Brandén, Lars ^a   Cosman, David ^d   Söderberg Nauclér, Cecilia ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Evanston NW Hlthcare Res Inst   (United States)

^d AMGEN INC   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; GREEN FLUORESCENT PROTEIN; PERFORIN; PROTEIN UL16; STREPTOLYSIN O; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DELETION MUTANT; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SUPERNATANT; VIRUS STRAIN;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; GENE DELETION; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; STREPTOLYSINS; TRANSFECTION; VIRAL PROTEINS;

EID: 0345269959     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.8.4539-4545.2003     Document Type: Article

References (41)

1. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
2. Andersson, M., H. Gunne, B. Agerberth, A. Boman, T. Bergman, B. Olsson, A. Dagerlind, H. Wigzell, H. G. Boman, and G. H. Gudmundsson. 1996. NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells. Vet. Immunol. Immunopathol. 54:123-126.
3. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235-1238.
4. Browne, H., M. Churcher, and T. Minson. 1992. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 66:6784-6787.
5. Cerboni, C., M. Mousavi-Jazi, A. Linde, K. Soderstrom, M. Brytting, B. Wahren, K. Karre, and E. Carbone. 2000. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J. Immunol. 164:4775-4782.
6. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282.
7. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133.
8. Fletcher, J. M., H. G. Prentice, and J. E. Grundy. 1998. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J. Immunol. 161:2365-2374.
9. Froelich, C. J., K. Orth, J. Turbov, P. Seth, R. Gottlieb, B. Babior, G. M. Shah, R. C. Bleackley, V. M. Dixit, and W. Hanna. 1996. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271:29073-29079.
10. Froelich, C. J., J. Turbov, and W. Hanna. 1996. Human perforin: rapid enrichment by immobilized metal affinity chromatography (IMAC) for whole cell cytotoxicity assays. Biochem. Biophys. Res. Commun. 229:44-49.
11. Gilbert, M. J., S. R. Riddell, B. Plachter, and P. D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722.
12. Groh, V. V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255-260.
13. Hanna, W. L., X. Zhang, J. Turbov, U. Winkler, D. Hudig, and C. J. Froelich. 1993. Rapid purification of cationic granule proteases: application to human granzymes. Protein Expr. Purif. 4:398-404.
14. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hammerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623-632.
15. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977-987.
16. Hewitt, E. W., S. S. Gupta, and P. J. Lehner. 2001. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20:387-396.
17. Jones, T. R., and L. Sun. 1997. Human cytomegalovirus Us2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970-2979.
18. Jones, T. R., E. J. Wiertz, L. Sun, K. N. Fish, J. A. Nelson, and H. L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93:11327-11333.
19. Jun, Y., E. Kim, M. Jin, H. C. Sung, H. Han, D. E. Geraghty, and K. Ahn. 2000. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J. Immunol. 164:805-811.
20. Kaye, J., H. Browne, M. Stoffel, and T. Minson. 1992. The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J. Virol. 66:6609-6615.
21. Lehmann, C., M. Zeis, N. Schmitz, and L. Uharek. 2000. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96:594-600.
22. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Phillips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187:1681-1687.
23. + T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J. Virol. 73:6582-6589.
24. Machold, R. P., E. Wiertz, T. R. Jones, and H. L. Ploegh. 1997. The HCMV gene products Us11 and Us2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185:363-366.
25. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. Waldman, and D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
26. Miller, D. M., Y. Zhang, B. M. Rahill, W. J. Waldman, and D. D. Sedmak. 1999. Human cytomegalovirus inhibits IFN-α stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction. J. Immunol. 162:6107-6113.
27. Neighbour, P. A., H. S. Huberman, and Y. Kress. 1982. Human large granular lymphocytes and natural killing: ultrastructural studies of strontium-induced degranulation. Eur. J. Immunol. 12:588-595.
28. Odeberg, J., C. Cerboni, H. Browne, K. Kärre, E. Möller, E. Carbone, and C. Söderberg-Nauclér. 2001. Human cytomegalovirus (HCMV) infected endothelial cells and macrophages are less susceptible to NK lysis Independently of downregulation of classical HLA class I molecules, or expression of the HCMV class I homologue, UL18. Scand J. Immunol. 55:149-161.
29. Odeberg, J., and C. Soderberg-Naucler. 2001. Reduced expression of HLA class II molecules and interleukin-10- and transforming growth factor β1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J. Virol. 75:5174-5181.
30. Onno, M., C. Pangault, G. Le Friec, V. Guilloux, P. Andre, and R. Fauchet. 2000. Modulation of HLA-G antigen expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J. Immunol. 164:6426-6434.
31. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517.
32. Sedmak, D. D., A. M. Guglielmo, D. A. Knight, D. J. Birmingham, E. H. Huang, and W. J. Waldman. 1994. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am. J. Pathol. 144:683-692.
33. Söderberg-Naucler, C., and J. Y. Nelson. 1999. Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system. Intervirology 42:314-321.
34. Spaeny-Dekking, E. H., W. L. Hanna, A. M. Wolbink, P. C. Wever, A. J. Kummer, A. J. Swaak, J. M. Middeldorp, H. G. Huisman, C. J. Froelich, and C. E. Hack. 1998. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 160: 3610-3616.
35. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. McMichael, and G. W. G. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031-1033.
36. Tomazin, R., J. Boname, N. R. Hegde, D. M. Lewinsohn, Y. Altschuler, T. R. Jones, P. Cresswell, J. A. Nelson, S. R. Ridell, and D. C. Johnson. 1999. Cytomegalovirus US2 destroys two compartment of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 5:1039-1043.
37. Ulbrecht, M., S. Martinozzi, M. Grzeschik, H. Hengel, J. W. Ellwart, M. Pla, and E. H. Weiss. 2000. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164:5019-5022.
38. Waner, J. L., and J. A. Nierenberg. 1985. Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells. J. Med. Virol. 16:233-244.
39. Wang, E. C., B. McSharry, C. Retiere, P. Tomasec, S. Williams, L. K. Borysiewicz, V. M. Braud, and G. W. Wilkinson. 2002. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 99:7570-7575.
40. Warren, A. P., D. H. Ducroq, P. J. Lehner, and L. K. Borysiewicz. 1994. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:2822-2829.
41. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.